Mon, May 20, 2024
In press (Jan-Feb)
Back to the articles list |
Back to browse issues page
1- Department of Clinical Biochemistry University of Kashmir, Hazratbal, Srinagar, Kashmir, J&K India
2- Department of Biochemistry Govt Medical College and associated hospitals, Karan Nagar, Srinagar, Kashmir, J&K India
2- Department of Biochemistry Govt Medical College and associated hospitals, Karan Nagar, Srinagar, Kashmir, J&K India
Abstract: (77 Views)
Background: The complete blood count (CBC) profile has been found extremely useful in monitoring the growth of SARS-CoV-2 infection; however, predictive CBC parameters that could be used in the management of the disease may vary in different populations.
Methods: This study comparatively analyzed the CBC profile of SARS-CoV-2 patients (N = 75; confirmed positive by real-time polymerase chain reaction [PCR]) and healthy individuals (confirmed negative by real-time PCR) from Kashmir (north India).
Results: Compared with healthy individuals, most of the CBC parameters (hemoglobin levels [13.43 vs 10.9 g/dL; P = 0.0001], lymphocytes [16.04% vs 30.8%; P = 0.00001], monocytes [5.53% vs 7.53%; P = 0.009], and platelet count [150 vs 186 ×103 µL; P = 0.037]) were significantly low in SARS-CoV-2 infected patients, while neutrophilia was more common in infected patients (76.77% vs 59.26%). Among derived parameters, the neutrophil-to-lymphocyte ratio (NLR; 7.31 vs 2.04; P = 0.001) and derived NLR (d-NLR; 4.43 vs 1.5; P = 0.0002) were significantly high in SARS-CoV-2 patients. Further correlation analysis revealed a significant association of neutrophilia with the severity of the disease in SARS-CoV-2 infected patients. Moreover, receiver operating characteristic (ROC) analysis of derived CBC parameters (NLR, d-NLR, and platelet‐to-lymphocyte ratio [PLR] with disease severity and disease outcome) revealed d-NLR as better predictive marker of disease severity (area under the curve [AUC] = 0.658) and disease outcome (AUC = 0.766) compared to PLR with disease severity (AUC = 0.645) and disease outcome (AUC = 0.693).
Conclusion: We therefore conclude, of the CBC parameters neutrophilia as the marker of disease severity and among derived parameters, d-NLR as an early predictive biomarker of both disease severity and poor disease outcome in SARS-CoV-2 patients.
Methods: This study comparatively analyzed the CBC profile of SARS-CoV-2 patients (N = 75; confirmed positive by real-time polymerase chain reaction [PCR]) and healthy individuals (confirmed negative by real-time PCR) from Kashmir (north India).
Results: Compared with healthy individuals, most of the CBC parameters (hemoglobin levels [13.43 vs 10.9 g/dL; P = 0.0001], lymphocytes [16.04% vs 30.8%; P = 0.00001], monocytes [5.53% vs 7.53%; P = 0.009], and platelet count [150 vs 186 ×103 µL; P = 0.037]) were significantly low in SARS-CoV-2 infected patients, while neutrophilia was more common in infected patients (76.77% vs 59.26%). Among derived parameters, the neutrophil-to-lymphocyte ratio (NLR; 7.31 vs 2.04; P = 0.001) and derived NLR (d-NLR; 4.43 vs 1.5; P = 0.0002) were significantly high in SARS-CoV-2 patients. Further correlation analysis revealed a significant association of neutrophilia with the severity of the disease in SARS-CoV-2 infected patients. Moreover, receiver operating characteristic (ROC) analysis of derived CBC parameters (NLR, d-NLR, and platelet‐to-lymphocyte ratio [PLR] with disease severity and disease outcome) revealed d-NLR as better predictive marker of disease severity (area under the curve [AUC] = 0.658) and disease outcome (AUC = 0.766) compared to PLR with disease severity (AUC = 0.645) and disease outcome (AUC = 0.693).
Conclusion: We therefore conclude, of the CBC parameters neutrophilia as the marker of disease severity and among derived parameters, d-NLR as an early predictive biomarker of both disease severity and poor disease outcome in SARS-CoV-2 patients.
Research Article: Research Article |
Subject:
Biochemistry
Received: 2023/02/20 | Accepted: 2023/10/15
Received: 2023/02/20 | Accepted: 2023/10/15
References
1. WHO. Novel coronavirus - China. 2020. [View at Publisher] [Google Scholar]
2. WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020. [View at Publisher]
3. WHO. WHO COVID-19 dashboard: COVID-19 cases. 2023. [View at Publisher]
4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Xiang N, Havers F, Chen T, Song Y, Tu W, Li L, et al. Use of national pneumonia surveillance to describe influenza A (H7N9) virüs epidemiology, China, 2004-2013. Emerg Infect Dis. 2013;19(11):1784‐90. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, et al. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Front Med. 2020;7:301. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Soylu K, Gedikli Ö, Ekşi A, Avcıoğlu Y, İdil Soylu A, Yüksel S et al. Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism. Arch Med Sci. 2016;12(1):95-100. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107:695-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome. Kaohsiung J Med Sci. 2015;31(12):626-31. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234(1):206-13. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(19):32171-89 [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d‐NLR and PLR in COVID‐19 patients. Int Immunopharmacol. 2020;84:106504. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. National Institutes of Health. COVID-19 Treatment Guidelines Panel; Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2022. [View at Publisher]
14. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020;4(4):66-75. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Cecconi M, Piovani D, Brunetta E, Aghemo A, Greco M, Ciccarelli M, et al. Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy. J Clin Med. 2020;9(5):1548. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber M, et al. Prevalence and predictive value of Anemia and Dysregulated Iron homeostasis in patients with COVID-19 infection. J Clin Med. 2020;9(8):2429. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248(3):171-183. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Blaser MJ, Chyou PH, Nomura A. Age at Establishment of Helicobacter pylori Infection and Gastric Carcinoma, Gastric Ulcer, and Duodenal Ulcer Risk. Cancer Res. 1995;55(3):562-5. [View at Publisher] [PMID] [Google Scholar]
19. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L, et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J NatI Cancer Inst. 1994;86(2):120-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002;16(2):217-26. [View at Publisher] [PMID] [Google Scholar]
21. Kusumanto YH, Dam WA, Hospers GAP, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Kim SL, Lee ST, Trang KTT, Kim SH, Kim IH, Lee SO. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. Int J Mol Med. 2014;33(5):1261-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002;169(8):4288-97. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109(9):3812-19. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Dutta P, Nahrendorf M. Regulation and consequences of monocytosis. Immunol Rev. 2014;262(1):167-78. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Assinger A. Platelets and infection - an emerging role of platelets in viral infection. Front Immunol. 2014;5:649. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Seyoum M, Enawgaw B, Melku M. Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens. Thromb J. 2018;16(1):16. [View at Publisher] [DOI] [PMID] [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.